Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

OBJECTIVE: Parkinson’s disease (PD) is a neurological disorder, and ergot dopamine agonists (DAs) are no longer usually preferred in the treatment due to the increased risk of valvular heart disease. Some recent studies have shown that commonly used non-ergot DA also increases the risk of heart fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Pamukcu, Hilal Erken, Uludağ, Demet Menekşe Gerede, Tak, Bahar Tekin, Sorgun, Mine Hayriye, Efe, Tolga Han, Acıbuca, Aynur, Akbostancı, Cenk, Turhan, Sibel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249529/
https://www.ncbi.nlm.nih.gov/pubmed/30297579
http://dx.doi.org/10.14744/AnatolJCardiol.2018.65983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249529/
https://www.ncbi.nlm.nih.gov/pubmed/30297579
http://dx.doi.org/10.14744/AnatolJCardiol.2018.65983

Ejemplares similares